Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Knowing when to invest with your savings can significantly impact your returns. Explore the best timing strategies for your investments.
17,373 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Alphabet plans nearly $185B in capital spending for 2026, mostly on data centers. This article highlights a crucial m...
Inflation has squeezed most Americans, but American Express remains focused on the affluent. This article examines wh...
As of June 26, 2026, the Invesco KBW High Dividend Yield Financial ETF faces renewed scrutiny over whether its double...
A timely look at two Roth conversion advantages highlighted by Dave Ramsey. The piece explains how these perks could ...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
Investors eye the physical ai’s trillion opportunity—a potential $50 trillion payoff from industrial AI—but it requir...
Memory plays a critical role in AI growth, and micron's data center gross margin has surged to industry-leading level...
Google and Apple are leading the AI stock surge. This piece weighs valuation, growth, and cash flow to answer which m...
A 75-year-old with $1.3M faces a $58,000 RMD that could tax most of his Social Security, illustrating how tax rules c...
A strong quarter from TSMC is more than a one-off beat. This analysis explains why tsmc's revenue grew last and how c...